Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Neurological Medicine
Volume 2015, Article ID 453752, 3 pages
http://dx.doi.org/10.1155/2015/453752
Case Report

Severe Hyperammonemia in Late-Onset Ornithine Transcarbamylase Deficiency Triggered by Steroid Administration

1Unitat de Diagnòstic i Tractament de les Demències, Neurology Service, Hospital Universitari de Bellvitge, Feixa Llarga s/n, 08907 L’Hospitalet de Llobregat, Spain
2Neurology Service, Hospital Universitari Parc Taulí, Parc del Taulí 1, 08208 Sabadell, Spain

Received 24 November 2014; Accepted 29 March 2015

Academic Editor: Majaz Moonis

Copyright © 2015 Jordi Gascon-Bayarri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. M. Panlaqui, K. Tran, A. Johns, J. McGill, and H. White, “Acute hyperammonemic encephalopathy in adult onset ornithine transcarbamylase deficiency,” Intensive Care Medicine, vol. 34, no. 10, pp. 1922–1924, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. C. M. Rüegger, M. Lindner, D. Ballhausen et al., “Cross-sectional observational study of 208 patients with non-classical urea cycle disorders,” Journal of Inherited Metabolic Disease, vol. 37, no. 1, pp. 21–30, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Cavicchi, M. Donati, R. Parini et al., “Sudden unexpected fatal encephalopathy in adults with OTC gene mutations-Clues for early diagnosis and timely treatment,” Orphanet Journal of Rare Diseases, vol. 9, article 105, 2014. View at Publisher · View at Google Scholar
  4. S. Heringlake, K. Böker, and M. Manns, “Fatal clinical course of ornithine transcarbamylase deficiency in an adult heterozygous female patient,” Digestion, vol. 58, no. 1, pp. 83–86, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. D. L. Roberts, D. A. Galbreath, B. M. Patel, T. J. Ingall, A. Khatib, and D. J. Johnson, “Hyperammonemic coma in an adult due to ornithine transcarbamylase deficiency,” Case Reports in Critical Care, vol. 2013, Article ID 493216, 4 pages, 2013. View at Publisher · View at Google Scholar
  6. S. Lipskind, S. Loanzon, E. Simi, and D. W. Ouyang, “Hyperammonemic coma in an ornithine transcarbamylase mutation carrier following antepartum corticosteroids,” Journal of Perinatology, vol. 31, no. 10, pp. 682–684, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. C. Machado, G. M. Fonseca, and J. Jukemura, “Late-onset ornithine carbamoyltransferase deficiency accompanying acute pancreatitis and hyperammonemia,” Case Reports in Medicine, vol. 2013, Article ID 903546, 3 pages, 2013. View at Publisher · View at Google Scholar
  8. N. F. Blair, P. D. Cremer, and M. C. Tchan, “Urea cycle disorders: a life-threatening yet treatable cause of metabolic encephalopathy in adults,” Practical Neurology, vol. 15, no. 1, pp. 45–48, 2015. View at Publisher · View at Google Scholar
  9. M. L. Summar, F. Barr, S. Dawling et al., “Unmasked adult-onset urea cycle disorders in the critical care setting,” Critical Care Clinics, vol. 21, no. 4, pp. S1–S8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Atiq, A. F. Holt, K. Safdar et al., “Adult onset urea cycle disorder in a patient with presumed hepatic encephalopathy,” Journal of Clinical Gastroenterology, vol. 42, no. 2, pp. 213–214, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. R. J. Hawley, “Hyperammonia possibly due to corticosteroids,” Archives of Neurology, vol. 57, no. 7, pp. 1085–1086, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Löfberg, A. Gutierrez, J. Wernerman et al., “Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle,” European Journal of Clinical Investigation, vol. 32, no. 5, pp. 345–353, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. D. E. Choi, K. W. Lee, Y. T. Shin, and K. R. Na, “Hyperammonemia in a patient with late-onset ornithine carbamoyltransferase deficiency,” Journal of Korean Medical Science, vol. 27, no. 5, pp. 556–559, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Häberle, N. Boddaert, A. Burlina et al., “Suggested guidelines for the diagnosis and management of urea cycle disorders,” Orphanet Journal of Rare Diseases, vol. 7, no. 1, article 32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Yamaguchi, L. L. Brailey, H. Morizono, A. E. Bale, and M. Tuchman, “Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene,” Human Mutation, vol. 27, no. 7, pp. 626–632, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. E. R. Hauser, J. E. Finkelstein, D. Valle, and S. W. Brusilow, “Allopurinol-induced orotidinuria: a test for mutations at the ornithine carbamoyltransferase locus in women,” The New England Journal of Medicine, vol. 322, no. 23, pp. 1641–1645, 1990. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Lien, W. L. Nyhan, and B. A. Barshop, “Fatal initial adult-onset presentation of urea cycle defect,” Archives of Neurology, vol. 64, no. 12, pp. 1777–1779, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. O. P. Van Diggelen, J. Zaremba, W. He et al., “Asymptomatic and late-onset ornithine transcarbamylase (OTC) deficiency in males of a five-generation family, caused by an A208T mutation,” Clinical Genetics, vol. 50, no. 5, pp. 310–316, 1996. View at Google Scholar · View at Scopus
  19. O. D. Klein, D. R. Kostiner, K. Weisiger et al., “Acute fatal presentation of ornithine transcarbamylase deficiency in a previously healthy male,” Hepatology International, vol. 2, no. 3, pp. 390–394, 2008. View at Publisher · View at Google Scholar · View at Scopus